Published in Kidney Int on June 01, 1992
Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest (1995) 1.50
Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest (1993) 1.00
Attenuation of adrenomedullin-induced renal vasodilatation by NG-nitro L-arginine but not glibenclamide. Br J Pharmacol (1995) 0.84
The protective effects of green tea extract against L-arginine toxicity to cultured human mesangial cells. J Korean Med Sci (2009) 0.83
Interaction of nitric oxide and cyclic guanosine 3',5'-monophosphate in erythropoietin production. J Clin Invest (1993) 0.81
Sildenafil Ameliorates Gentamicin-Induced Nephrotoxicity in Rats: Role of iNOS and eNOS. J Toxicol (2014) 0.76
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation (1997) 2.20
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum (1998) 1.86
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Mechanism of antihypertensive action of ketanserin in man. Br Med J (Clin Res Ed) (1983) 1.47
L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol (1998) 1.39
[Aspirin--yes, but 30 mg??]. Z Kardiol (1995) 1.39
Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. J Oral Maxillofac Surg (1995) 1.36
Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res (1987) 1.35
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol (1999) 1.32
Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett (2000) 1.29
Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res (1980) 1.25
Effect of dexamethasone on in vivo prostanoid production in the rabbit. J Clin Invest (1984) 1.24
Nitric oxide and inflammatory joint diseases. Br J Rheumatol (1998) 1.22
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. J Biol Chem (1980) 1.21
Extraction and chromatographic procedures for purification of prostaglandins, thromboxanes, prostacyclin, and their metabolites. Adv Prostaglandin Thromboxane Res (1978) 1.19
Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun (1996) 1.19
L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci (Lond) (1994) 1.14
Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. J Pharmacol Exp Ther (1986) 1.10
Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells. J Pharmacol Exp Ther (1991) 1.06
Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology (1997) 1.05
Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol (1991) 1.05
L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation (1996) 1.05
Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation (1997) 1.04
The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res (1978) 1.03
Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol (1978) 1.03
Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth. Eur J Clin Pharmacol (1993) 1.03
The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med (1978) 1.02
Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis (1995) 1.01
Indomethacin increases plasma lithium. Br Med J (1979) 1.01
Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest (1997) 1.01
Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol (1994) 1.00
Mechanisms of action of lipoxygenase and cytochrome P-450-mono-oxygenase inhibitors in blocking endothelium-dependent vasodilatation. Br J Pharmacol (1988) 1.00
Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther (1975) 0.99
Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. J Clin Invest (1993) 0.98
Endothelium-derived relaxing factor influences renal vascular resistance. Am J Physiol (1990) 0.97
Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.97
Effects of cimetidine and ranitidine on steady-state propranolol kinetics and dynamics. Clin Pharmacol Ther (1982) 0.97
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol (1998) 0.96
Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state. Eur J Clin Pharmacol (1983) 0.96
Effects of diclofenac on lithium kinetics. Clin Pharmacol Ther (1981) 0.95
Regional differences in prostacyclin formation by the kidney. Prostacyclin is a major prostaglandin of renal cortex. Biochim Biophys Acta (1978) 0.95
Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney Int (1996) 0.94
Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers. J Cardiovasc Pharmacol (1986) 0.94
Endothelium-dependent relaxation of human epicardial coronary arteries: frequent lack of effect of acetylcholine. Eur J Pharmacol (1986) 0.94
Influence of cyclosporine A on adaptive hypertrophy after unilateral nephrectomy in the rat. Clin Nephrol (1986) 0.93
Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat. Br J Pharmacol (1987) 0.93
Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br J Clin Pharmacol (1990) 0.92
Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res (1988) 0.91
Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography-mass spectrometry using their 15N-labelled analogs. J Chromatogr B Biomed Appl (1994) 0.91
Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay--solutions by gas chromatography-mass spectrometry. Anal Biochem (1997) 0.91
The participation of prostaglandins in the control of renin release. Fed Proc (1979) 0.91
Indomethacin but not aspirin increases plasma lithium ion levels. Arch Gen Psychiatry (1983) 0.91
Investigations of S-transnitrosylation reactions between low- and high-molecular-weight S-nitroso compounds and their thiols by high-performance liquid chromatography and gas chromatography-mass spectrometry. Anal Biochem (1999) 0.91
[Incidence and prevention of lethal undesirable drug effects]. Internist (Berl) (2003) 0.91
Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention. Circ Res (1979) 0.90
Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (1998) 0.90
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol (2002) 0.90
Exercise increases systemic nitric oxide production in men. J Cardiovasc Risk (1994) 0.89
Effect of aprotinin on the renal response to vasopressin in diabetes insipidus rats. J Physiol (1983) 0.89
Measurement of prostaglandins, thromboxanes, prostacyclin and their metabolites by gas liquid chromatography--mass spectrometry. Adv Prostaglandin Thromboxane Res (1978) 0.89
Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine. J Chromatogr B Biomed Sci Appl (1998) 0.88
Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol (1986) 0.88
Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol (2000) 0.88
Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein binding. Clin Nephrol (2004) 0.88
Quantitative determination of prostaglandins. Prostaglandins (1973) 0.88
Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis (1995) 0.87
Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits. Atherosclerosis (1998) 0.87
Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus. J Pharmacol Exp Ther (1981) 0.87
Role of albumin and glomerular capillary wall charge distribution on glomerular permselectivity: studies on the perfused-fixed rat kidney model. Pflugers Arch (1999) 0.87
Determination of S-nitrosoglutathione in human and rat plasma by high-performance liquid chromatography with fluorescence and ultraviolet absorbance detection after precolumn derivatization with o-phthalaldehyde. Anal Biochem (1999) 0.87
Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension. Hypertension (1981) 0.86
Urinary prostaglandin and kallikrein excretion are not flow dependent in the rat. Prostaglandins (1983) 0.86
Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis (1998) 0.86
Effects of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man. Eur J Clin Pharmacol (1996) 0.86
Mechanism of PAF-induced platelet aggregation in man. Thromb Res (1986) 0.86
COX-2 and the kidneys. Curr Pharm Des (2000) 0.86
Effects of nonsteroidal phospholipase inhibitors and glucocorticoids on endothelium-dependent relaxations of rabbit aorta induced by different agents. J Cardiovasc Pharmacol (1987) 0.85
Measurement of S-nitrosoalbumin by gas chromatography-mass spectrometry. II. Quantitative determination of S-nitrosoalbumin in human plasma using S-[15N]nitrosoalbumin as internal standard. J Chromatogr B Biomed Sci Appl (1999) 0.85
Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin. J Appl Physiol (1985) (1995) 0.85
Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance. Eur J Clin Pharmacol (1985) 0.85
Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Investig Med (1997) 0.85
Characterization of prostaglandin E receptor in membranes and its use in the assay of prostaglandin E. Methods Enzymol (1974) 0.85
Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets. FEBS Lett (1999) 0.85
Relevance of urinary 6-keto-prostaglandin F1 alpha determination. Kidney Int (1981) 0.84
Dexamethasone effect on prostanoid formation in healthy man. Clin Sci (Lond) (1985) 0.84
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease? Nephrol Dial Transplant (2001) 0.84
L-arginine stimulates NO-dependent vasodilation in healthy humans--effect of somatostatin pretreatment. J Investig Med (1999) 0.84
Glomerular albumin leakage and morphology after neutralization of polyanions. II. Discrepancy of protamine induced albuminuria and fine structure of the glomerular filtration barrier. J Submicrosc Cytol (1984) 0.84
Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine. J Chromatogr B Biomed Sci Appl (2000) 0.84
Effect of arginine depletion on glomerular and tubular kidney function: studies in isolated perfused rat kidneys. Am J Physiol (1991) 0.84